You are viewing an incomplete version of our website. Please click to reload the website as full version.

Potassium Channel Regulator (KCNRG) (AA 182-210), (C-Term) Antikörper

Details zu Produkt Nr. ABIN953017, Anbieter: Anmelden zum Anzeigen Neu
Neu
Request Mehr Daten zu diesem Produkt gewünscht?

Unabhängige Labortests können diese liefern Mehr

Antigen
Synonyme DLTET, Clld4, E030012H22Rik, Gm745
Epitop
AA 182-210, C-Term
(17), (16), (10), (3), (2), (2), (2), (1)
Reaktivität
Human, Maus
(27), (13), (3), (3), (3)
Wirt
Kaninchen
(36), (3)
Klonalität
Polyklonal
Konjugat
Unkonjugiert
(2), (2), (2), (2), (2), (2)
Applikation
Enzyme Immunoassay (EIA), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
(36), (17), (16), (2)
Pubmed 5 Publikationen vorhanden
Hersteller Anmelden zum Anzeigen Neu
Produkt-ID vom Hersteller Anmelden zum Anzeigen Neu
Menge 0.4 mL
Lieferung nach Deutschland ( )
Verfügbarkeit Lieferung in 8 bis 10 Werktagen
Immunogen KLH conjugated synthetic peptide between 182-210 amino acids from the C-terminal region of human KCNRG
Isotyp Ig
Spezifität This antibody recognizes Human and Mouse KCNRG (C-term).
Reinigung Protein A column, followed by peptide affinity purification
Andere Bezeichnung KCNRG (KCNRG Antibody Abstract)
Hintergrund This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This gene is located on chromosome 13 within the minimal deletion region for B-cell chronic lymphocytic leukemia. Multiple alternatively spliced transcript variants have been found for this gene.Synonyms: CLLD4, KCNRG, Potassium channel regulator, Potassium channel regulatory protein, Protein CLLD4
Molekulargewicht 31048 Da
Gen-ID 10206
NCBI Accession NP_001007279
Forschungsgebiet Cancer
Pathways
Applikationshinweise Optimal working dilution should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 0.25 mg/mL
Buffer PBS containing 0.09 % (W/V) Sodium Azide as preservative
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung Avoid repeated freezing and thawing.
Lagerung 4 °C/-20 °C
Informationen zur Lagerung Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Bilder des Herstellers
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-Potassium Channel Regulator (KCNRG) (AA 182-210), (C-Term) Antikörper (ABIN953017) Immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tis...
Western Blotting (WB) image for anti-Potassium Channel Regulator (KCNRG) (AA 182-210), (C-Term) Antikörper (ABIN953017) Western blot analysis of KCNRG Antibody (C-term) in mouse liver,lung tissue lysates (...
Allgemeine Veröffentlichungen Lerner, Corcoran, Cepeda et al.: "The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD." in: Molecular biology of the cell, Vol. 18, Issue 5, pp. 1670-82, 2007 (PubMed).

Skoblov, Shakhbazov, Oshchepkov et al.: "Human RFP2 gene promoter: unique structure and unusual strength." in: Biochemical and biophysical research communications, Vol. 342, Issue 3, pp. 859-66, 2006 (PubMed).

Corcoran, Hammarsund, Zhu et al.: "DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse." in: Genes, chromosomes & cancer, Vol. 40, Issue 4, pp. 285-97, 2004 (PubMed).

Dunham, Matthews, Burton et al.: "The DNA sequence and analysis of human chromosome 13. ..." in: Nature, Vol. 428, Issue 6982, pp. 522-8, 2004 (PubMed).

van Everdink, Baranova, Lummen et al.: "RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia." in: Cancer genetics and cytogenetics, Vol. 146, Issue 1, pp. 48-57, 2003 (PubMed).

Produktnummer ABIN953017
418,00 €
Zzgl. Versandkosten 20,00 € und MWSt

Bestellen Sie auch über:

  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155